Merck KGaA

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 09:05:29 17/05/2024 pm IST 5-day change 1st Jan Change
167.2 EUR -0.89% Intraday chart for Merck KGaA +7.39% +16.03%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
MERCK KGAA : DZ Bank gives a Buy rating ZD
MERCK KGAA : Gets a Buy rating from Barclays ZD
EU GDP Estimates, Rosy Spring Forecast Prop Up German Stocks MT
MERCK : Electronics came as a big surprise Alphavalue
Transcript : Merck KGaA, Q1 2024 Earnings Call, May 15, 2024
UBS rates Merck KGaA a 'Buy' - Target 186 euros DP
Upbeat earnings lift European shares to record high ahead of US inflation data RE
MERCK KGAA : UBS maintains a Buy rating ZD
Positive quarterly report pushes Merck KGaA to annual high DP
Merck KGaA: 13% decline in quarterly adjusted EPS CF
Industrials lift European shares to record high ahead of US inflation data RE
Merck KGaA Posts Lower Q1 Attributable Profit, Net Sales MT
Merck KGaA's Q1 adjusted profit declines less than feared RE
Merck KGaA Confirms Outlook After Drop in Sales, Earnings DJ
Merck KGaA Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Cinven to explore $3 billion sale of software maker Jaggaer, sources say RE
MERCK KGAA : UBS reiterates its Buy rating ZD
MERCK KGAA : Gets a Buy rating from JP Morgan ZD
MERCK KGAA : Receives a Buy rating from Deutsche Bank ZD
Biocartis, Merck KGaA Expand Cancer Biomarker Testing Collaboration into MENA Region MT
MERCK KGAA : Gets a Buy rating from UBS ZD
Biocartis Announces Expansion of Its Collaboration with Merck Serono Middle East and North Africa CI
MERCK KGAA : JP Morgan maintains a Buy rating ZD
MERCK KGAA : Jefferies keeps its Buy rating ZD
Habeck's 'pharma trip' - industry sees structural problems DP
Chart Merck KGaA
More charts
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
167.2 EUR
Average target price
180.8 EUR
Spread / Average Target
+8.10%
Consensus
  1. Stock Market
  2. Equities
  3. MRK Stock
  4. News Merck KGaA
  5. Merck Enlists 2 UK AI Companies to Collaborate on Drug Discoveries
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW